DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Oral microbiome and mycobiome dynamics in cancer therapy-induced oral mucositis

Journal Article · · Scientific Data (Online)
 [1];  [2];  [1];  [1];  [3];  [1];  [4]; ORCiD logo [4];  [1];  [4]; ORCiD logo [4]
  1. University of Tennessee, Knoxville, TN (United States)
  2. University of Tennessee, Knoxville, TN (United States); Genesis Care of North Carolina, Asheville, NC (United States)
  3. University of Tennessee, Memphis, TN (United States)
  4. Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)

Cancer therapy-induced oral mucositis is a frequent major oncological problem, secondary to cytotoxicity of chemo-radiation treatment. Oral mucositis commonly occurs 7–10 days after initiation of therapy; it is a dose-limiting side effect causing significant pain, eating difficulty, need for parenteral nutrition and a rise of infections. The pathobiology derives from complex interactions between the epithelial component, inflammation, and the oral microbiome. Our longitudinal study analysed the dynamics of the oral microbiome (bacteria and fungi) in nineteen patients undergoing chemo-radiation therapy for oral and oropharyngeal squamous cell carcinoma as compared to healthy volunteers. The microbiome was characterized in multiple oral sample types using rRNA and ITS sequence amplicons and followed the treatment regimens. Microbial taxonomic diversity and relative abundance may be correlated with disease state, type of treatment and responses. Identification of microbial-host interactions could lead to further therapeutic interventions of mucositis to re-establish normal flora and promote patients’ health. Data presented here could enhance, complement and diversify other studies that link microbiomes to oral disease, prophylactics, treatments, and outcome.

Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE; USDOE Laboratory Directed Research and Development (LDRD) Program
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
2533582
Journal Information:
Scientific Data (Online), Journal Name: Scientific Data (Online) Journal Issue: 1 Vol. 12; ISSN 2052-4463
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (26)

Reporting results of cancer treatment journal January 1981
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy journal July 2020
Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck journal September 2023
QIIME 2 Enables Comprehensive End‐to‐End Analysis of Diverse Microbiome Data and Comparative Studies with Publicly Available Data journal April 2020
The pathogenesis of mucositis: updated perspectives and emerging targets journal July 2019
Modifications of the microflora of the oral cavity arising during immunosuppressive chemotherapy journal September 1996
Extensive Unexplored Human Microbiome Diversity Revealed by Over 150,000 Genomes from Metagenomes Spanning Age, Geography, and Lifestyle journal January 2019
Influence of the microbiome on radiotherapy-induced oral mucositis and its management: A comprehensive review journal September 2023
Antimicrobial therapy to prevent or treat oral mucositis journal July 2003
A framework for human microbiome research journal June 2012
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 journal July 2019
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines journal May 2010
Research Frontiers in Oral Toxicities of Cancer Therapies: Osteoradionecrosis of the Jaws journal August 2019
The UNITE database for molecular identification and taxonomic communication of fungi and other eukaryotes: sequences, taxa and classifications reconsidered journal November 2023
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools journal November 2012
The role of oral flora in the development of chemotherapy‐induced oral mucositis journal February 2014
Recent advances in cancer therapy‐associated oral mucositis journal July 2024
The microbiome and human cancer journal March 2021
Host-Microbiome Cross-talk in Oral Mucositis journal April 2016
Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis journal April 2019
ROMAN: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC). journal June 2022
Current Trends in Management of Oral Mucositis in Cancer Treatment journal August 2017
Topical Treatment of Oral Mucositis in Cancer Patients: A Systematic Review of Randomized Clinical Trials journal July 2020
Oral microbiota dysbiosis accelerates the development and onset of mucositis and oral ulcers journal February 2023
From Pathogenesis to Intervention: The Importance of the Microbiome in Oral Mucositis journal May 2023
Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review journal November 2023

Similar Records

Randomized Phase 3, Double-blind, Placebo-controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma
Journal Article · 2022 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:23200891

The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy
Journal Article · 1994 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:6582952

Oral complications of cancer therapies. Management of mucositis during therapy
Journal Article · 1989 · NCI Monographs (National Cancer Institute); (USA) · OSTI ID:6743349

Related Subjects